Integrated clinical, genomic and functional characterization of a novel ALK variant in neuroblastoma

Affiliations

• 1 Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, CB20QQ, UK.
• 2 Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Sweden; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
• 3 CRUK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
• 4 Newcastle Genetics Laboratory, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle Upon Tyne, UK.
• 5 Department of Paediatric Oncology, Royal Manchester Children's Hospital, Division of Cancer Sciences, University of Manchester & Manchester Centre for Genomic Medicine, Manchester, M13 9WL, UK.
• 6 Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, CB20QQ, UK; European Research Initiative for ALK Related Malignancies (ERIA), UK; Faculty of Medicine, Masaryk University, Brno, Czech Republic. Electronic address: [email protected].
• 7 Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, CB20QQ, UK. Electronic address: [email protected].